Mainstream

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Capricor signals readiness for deramiocel approval with $145M in cash and expanded commercial launch preparations

Post ContentcaprRead More

You might also be interested in reading Retail Traders Flock to Prediction Platforms; Kalshi Hits $4.4 Billion Volume in October.

May 14, 2025
In Mainstream